Pipeline

Pipeline

2024

2025

2026

2027-2028

1-6

7-12

1-6

7-12

PDT(Lung cancer)

In vivo

Preclinical

Clinical I

Clinical II

Triple negative breast cancer

In vivo

Preclinical

Clinical I

Clinical II

Pancreatic Cancer

In vivo

Preclinical

Clinical I

Clinical II

Colon Cancer

In vivo

Preclinical

Clinical I

Clinical II

AFC(Licensing)

Lisensing out